Evaluation of efficacy of chemotherapy for mucinous carcinoma: a surveillance, epidemiology, and end results cohort study.

ABSTRACT:

Background

In this study, we investigated the impact of chemotherapy on breast cancer-specific survival (BCSS) in patients with mucinous carcinoma using the surveillance, epidemiology, and end results (SEER) database.

Methods

A large-scale SEER-based retrospective analysis was conducted; 13,329 patients with mucinous carcinoma from 1994 to 2014 were identified. Clinicopathological characteristics were compared using the chi-square test. BCSS curves were generated using the Kaplan-Meier method. The prognostic significance of all demographic and clinicopathological characteristics and treatment patterns were calculated using univariate and multivariate regression analyses.

Results

Mucinous carcinoma was demonstrated to be less aggressive than invasive duct

SUBMITTER: Zhang H 

PROVIDER: S-EPMC7758869 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature